MTOR and central nervous system cancer: M2 macrophage-sourced exosomal miR-15a and miR-92a are reversely corroborated to inhibit glioma invasion and migration via phosphatidylinositol-3-kinase (PI3K)-AKT-mTOR pathway (223).